National Joint Registry - Data Management, Solutions, Statistical Analysis, Reporting & Associated Services

{
  "id": "075692-2026",
  "tag": [
    "tender"
  ],
  "date": "2026-08-10T12:29:44+01:00",
  "ocid": "ocds-h6vhtk-0699ce",
  "buyer": {
    "id": "GB-PPON-PVVQ-6113-CJWD",
    "name": "Healthcare Quality Improvement Partnership Ltd"
  },
  "tender": {
    "id": "HQIP 1036520245",
    "lots": [
      {
        "id": "1",
        "value": {
          "amount": 36689910,
          "currency": "GBP",
          "amountGross": 44027892
        },
        "status": "active",
        "renewal": {
          "description": "Up to £2,916,000 GBP per year including VAT, £2,430,000 GBP per year excluding VAT.\nThis proposed extension value will also include pro rata funding of any additional aspirational measures invoked in the first 5 years of the contract. For example:\nIf an aspirational annual requirement costing £500,000 per year is invoked in year 5 then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year."
        },
        "hasRenewal": true,
        "awardCriteria": {
          "criteria": [
            {
              "name": "SERVICE DELIVERY MODEL, MOBILISATION, TRANSITION AND EXIT",
              "type": "quality",
              "numbers": [
                {
                  "number": 11,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "DATA COLLECTION",
              "type": "quality",
              "numbers": [
                {
                  "number": 11,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "TECHNOLOGY PLATFORM AND SOLUTION ARCHITECTURE, SECURITY AND RESILIENCE",
              "type": "quality",
              "numbers": [
                {
                  "number": 6,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "SYSTEM DEVELOPMENT, CHANGE AND RELEASE MANAGEMENT",
              "type": "quality",
              "numbers": [
                {
                  "number": 5,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "STATISTICAL ANALYSIS, CLINICAL SURVEILLANCE AND OUTLIER MANAGEMENT",
              "type": "quality",
              "numbers": [
                {
                  "number": 11,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "CLINICAL LEADERSHIP AND OVERSIGHT",
              "type": "quality",
              "numbers": [
                {
                  "number": 4,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "PROJECT AND PROGRAMME MANAGEMENT",
              "type": "quality",
              "numbers": [
                {
                  "number": 4,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "INFORMATION GOVERNANCE",
              "type": "quality",
              "numbers": [
                {
                  "number": 4,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "CUSTOMER SUPPORT, STAKEHOLDER ENGAGEMENT AND TRAINING",
              "type": "quality",
              "numbers": [
                {
                  "number": 3,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "PERFORMANCE MANAGEMENT AND CONTINUOUS IMPROVEMENT",
              "type": "quality",
              "numbers": [
                {
                  "number": 2,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "REPORTING, DATA PRODUCTS AND STAKEHOLDER SERVICES",
              "type": "quality",
              "numbers": [
                {
                  "number": 4,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "INNOVATION AND ARTIFICIAL INTELLIGENCE",
              "type": "quality",
              "numbers": [
                {
                  "number": 2,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "INFORMATION GOVERNANCE, DATA ACCESS AND REGULATORY SUPPORT",
              "type": "quality",
              "numbers": [
                {
                  "number": 3,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "COST & ALLOCATION OF BUDGET",
              "type": "price",
              "numbers": [
                {
                  "number": 20,
                  "weight": "percentageExact"
                }
              ]
            },
            {
              "name": "SOCIAL VALUE",
              "type": "quality",
              "numbers": [
                {
                  "number": 10,
                  "weight": "percentageExact"
                }
              ]
            }
          ]
        },
        "contractPeriod": {
          "endDate": "2032-07-31T23:59:59+01:00",
          "startDate": "2027-08-01T00:00:00+01:00",
          "maxExtentDate": "2034-07-31T23:59:59+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      }
    ],
    "title": "National Joint Registry - Data Management, Solutions, Statistical Analysis, Reporting & Associated Services",
    "value": {
      "amount": 36689910,
      "currency": "GBP",
      "amountGross": 44027892
    },
    "status": "active",
    "documents": [
      {
        "id": "conflictOfInterest",
        "description": "Not published",
        "documentType": "conflictOfInterest"
      },
      {
        "id": "075692-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/075692-2026",
        "format": "text/html",
        "noticeType": "UK4",
        "description": "Tender notice on Find a Tender",
        "documentType": "tenderNotice",
        "datePublished": "2026-08-10T12:29:44+01:00"
      }
    ],
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "awardPeriod": {
      "endDate": "2027-01-13T23:59:59+00:00"
    },
    "description": "The contract will initially be delivered for Northern Ireland, Wales, England, Isle of Man, Jersey, Guernsey - both NHS and Independent sector hospitals, for a period of 5 years, at a maximum total budget of up to £14,580,000 GBP including VAT, £12,150,000 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years at a potential value of £2,916,000 GBP per year including VAT, £2,430,000 GBP per year excluding VAT. These extension values are based on no aspirational intent being invoked and are therefore subject to increase proportionally to the contract value if aspiration intent is invoked.\nAll pricing submissions must be in regard to this 'core' value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of £14,580,000 GBP including VAT, £12,150,000 GBP excluding VAT.\nThe maximum budget ‘core’ value excludes the potential two year extension and aspirational intent as described in section C of Annex A – Service Specification\nPlease note, there is no commitment by the Authority at this stage to include any aspirational intent measures. Taking the total of this aspirational intent into account, as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is £44,027,892 GBP including VAT, £36,689,910 GBP excluding VAT\nThere is also a potential that the contract price will be subject to discretionary inflationary uplifts.\nAbout the National Joint Registry \nThe National Joint Registry (NJR) is the largest orthopaedic joint replacement registry in the world. It collects, analyses and reports information on joint replacement procedures to improve patient safety, support clinical decision-making, monitor implant performance and improve the quality of care across the UK and Crown Dependencies. \nJoint replacement surgery is one of the most successful interventions in modern healthcare, restoring mobility and reducing pain for hundreds of thousands of patients. The NJR plays a critical role in monitoring the long-term performance of joint replacement implants and surgical techniques, providing robust evidence to clinicians, healthcare organisations, regulators, patients and the orthopaedic device industry. \nThe NJR was established in April 2002 by the Department of Health and the Welsh Government following recommendations arising from the National Audit Office investigation into the failure of the 3M Capital Hip System. Operational responsibility for the Registry transferred to the Healthcare Quality Improvement Partnership (HQIP) on 1 April 2008. \nThe Registry has progressively expanded its scope, collecting: \n•hip and knee replacement data since April 2003; \n•ankle replacement data since April 2010; and \n•shoulder and elbow replacement data since April 2012. \nThe geographical coverage of the Registry has also expanded to include: \n•Northern Ireland (2013); \n•the Isle of Man (2015); and \n•Guernsey (2019). \n•Jersey (2025) \nToday, the NJR contains data relating to millions of joint replacement procedures and continues to expand annually. It is recognised internationally as a leading clinical registry and provides an essential evidence base for improving outcomes, supporting research, informing procurement decisions and identifying patient safety concerns at the earliest opportunity. \nThe NJR is funded primarily through an annual subscription model based on eligible joint replacement procedures undertaken by NHS organisations and independent healthcare providers across participating nations. Since 2014, the orthopaedic device industry has also contributed through an annual subscription supporting supplier feedback services and related reporting. Income is managed by HQIP through a dedicated NJR fund under the governance of the NJR Board.\nThe Healthcare Quality Improvement Partnership (HQIP) is procuring a Supplier to deliver data collection, management and technology and statistical analysis and reporting.  \nThe successful Supplier will be responsible for the secure operation, maintenance and continuous development of the NJR's data management technology services and statistical analysis supporting one of the world's largest orthopaedic registries and enabling the delivery of high-quality information to patients, clinicians, healthcare providers, commissioners, regulators, researchers and the orthopaedic industry. \nThe procurement comprises: \n•Core Services \n•NJR data collection, data management and technology solutions; statistical analysis and reporting services. \nHQIP is seeking a strategic delivery partner that can demonstrate: \n•proven expertise in delivering secure, resilient and scalable data services; \n•a collaborative and solution-focused approach to partnership working; \n•innovation and a commitment to continuous service improvement; \n•responsiveness, flexibility and excellent customer service; \n•strong governance, information security and regulatory compliance; \n•the ability to identify opportunities to improve efficiency, data quality and user experience; and \n•effective communication and stakeholder engagement. \nThe successful Supplier will be expected to work collaboratively with HQIP to ensure seamless delivery of the Registry, maintaining continuity of service whilst supporting future innovation and development. \nOver the lifetime of the Contract, the Authority's ambitions include: \n•improving the quality, completeness and timeliness of data collection, validation and submission processes; \n•enhancing the resilience, scalability, performance and security of the Registry's technology platform; \n•increasing interoperability with NHS systems, national datasets and other relevant health and care services through open standards and modern APIs; \n•improving user experience through intuitive digital services, enhanced reporting capabilities and greater self-service functionality for stakeholders; \n•supporting more timely reporting, surveillance, analytics and insight generation to improve patient safety, clinical outcomes and service performance; \n•enabling the responsible adoption of automation, advanced analytics and emerging technologies, including artificial intelligence where appropriate and compliant with legal, ethical and information governance requirements; \n•strengthening cyber resilience, business continuity and operational sustainability; \n•supporting collaborative working across healthcare providers, patients, regulators, researchers, industry and other registries; \n•maintaining flexibility to adapt to future changes in clinical practice, regulatory requirements and national health policy; and \n•ensuring the Registry remains a leading international example of excellence in clinical registry management and medical device surveillance. \nThe scope of services includes: \n•Collection, processing and management of registry data through direct data entry, system interfaces and other approved data submission mechanisms; \n•Secure hosting, storage and management of NJR data and associated information assets; \n•Data validation, cleansing, quality assurance and reconciliation processes to maximise data accuracy, completeness and credibility; \n•Data linkage, comparison and reconciliation with relevant national and international datasets; \n•Development, operation and enhancement of continuous monitoring and surveillance systems, including implant and patient outcome monitoring; \n•Statistical analysis and reporting services, including:  \nooutlier detection and monitoring; \nodevelopment and maintenance of statistical methodologies; \noanalysis supporting patient safety, clinical effectiveness and service improvement; \noproduction of datasets and content for the NJR Annual Report; and \nodelivery of ad hoc analyses and data requests as required; \n•Production, publication and dissemination of reports, dashboards, datasets and stakeholder information services for patients, clinicians, healthcare providers, researchers, regulators and industry partners; \n•Preparation and provision of research-ready datasets and support for approved research activity; \n•Management of data access, disclosure and information governance processes, including patient data requests, research applications and regulatory requirements; \n•Provision of stakeholder support services, including helpdesk functions, user support, training, communications and maintenance of stakeholder contact databases; \n•Hosting, maintenance, development and operation of NJR stakeholder-facing digital services, including web-based reporting and information services; and \n•Provision of expert advice and support on registry development, data management, analytics, clinical surveillance and emerging best practice within the UK and internationally. \nFurther details of the existing programme can be found at: https://www.njrcentre.org.uk/",
    "riskDetails": "Full descriptive details of these measures, as well as the mechanisms for invoking them can be found in section C of Annex A - Service Specification.\nAll figures are inclusive of VAT\n1.Up to 24-month extension that mirrors the initial contract - Up to £5,832,000 plus a pro-rata of any costs invoked under aspirational intent\n2.Inclusion of additional devolved administrations - Up to £1,200,000\n3.Collection of imaging data – Up to £1,008,792\n4.Additional Registries – Up to £6,000,000\n5.New procedure types – Up to £3,000,000\n6.Expanded PROMs – Up to £6,167,100\n7.International benchmarking - £360,000\n8.Advanced predictive modelling & Enhanced use of automation, advanced analytics, and AI – Up to £3,600,000\n9.Progression toward a real-time or near real-time reporting system – Up to £900,000\n10.Improvement to user experience with additional intuitive design – Up to £600,000\n11.PROMs and patient reporting integration - Up to £360,000\n12.Back-office system integration – Up to £420,000",
    "tenderPeriod": {
      "endDate": "2026-10-14T12:00:00+01:00"
    },
    "contractTerms": {
      "financialTerms": "Payment will be made quarterly in arrears as described in the provider terms (Annex B). Disputed invoices will be dealt with as described in the provider terms (Annex B)"
    },
    "enquiryPeriod": {
      "endDate": "2026-09-25T12:00:00+01:00"
    },
    "aboveThreshold": true,
    "submissionTerms": {
      "languages": [
        "en"
      ],
      "electronicSubmissionPolicy": "allowed"
    },
    "procurementMethod": "open",
    "mainProcurementCategory": "services",
    "submissionMethodDetails": "https://www.delta-esourcing.com/respond/7449M9X8XA",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-PPON-PVVQ-6113-CJWD",
      "name": "Healthcare Quality Improvement Partnership Ltd",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI31",
        "country": "GB",
        "locality": "London",
        "postalCode": "EC2V 6DL",
        "countryName": "United Kingdom",
        "streetAddress": "c/o Buzzacott LLP, 130 Wood Street"
      },
      "details": {
        "classifications": [
          {
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - sub-central government"
          }
        ]
      },
      "identifier": {
        "id": "PVVQ-6113-CJWD",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "name": "Jonathan Williams",
        "email": "procurement@hqip.org.uk",
        "telephone": "0000000000"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}

{
  "id": "044829-2026",
  "tag": [
    "planning"
  ],
  "date": "2026-05-15T11:09:12+01:00",
  "ocid": "ocds-h6vhtk-0699ce",
  "buyer": {
    "id": "GB-PPON-PVVQ-6113-CJWD",
    "name": "Healthcare Quality Improvement Partnership Ltd"
  },
  "tender": {
    "id": "HQIP 1036520245",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "hasRenewal": true,
        "contractPeriod": {
          "endDate": "2032-07-31T23:59:59+01:00",
          "startDate": "2027-08-01T00:00:00+01:00",
          "maxExtentDate": "2034-07-31T23:59:59+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK",
            "country": "GB",
            "countryName": "United Kingdom"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      }
    ],
    "title": "National Joint Registry - Data Management, Solutions, Statistical Analysis, Reporting & Associated Services",
    "value": {
      "amount": 28400000,
      "currency": "GBP",
      "amountGross": 34080000
    },
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "description": "The contract is expected to initially be delivered for a period of 5 years, at a maximum total budget of up to £16,080,000 including VAT and £13,400,000 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other aspirational measures (which will be defined in the service specification) meaning the ceiling value has the potential to be higher.\nDue to the unknowns in advance of holding the premarket engagement session, it is currently expected that the extension value will be a 2 year pro rata of the core 5 year funding, estimated at £5,360,000 excluding VAT. \nThis proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first 5 years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year 5, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year.\nFurther to this funding, the final specification will contain a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, excluding the potential 2 year extension, is unknown at point of drafting this notice, so, an estimated value of £15,000,000 excluding VAT is applied to form the maximum total estimated value AT POINT OF DRAFTING THIS NOTICE. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures that will be listed in the final specification.\nThe Healthcare Quality Improvement Partnership (HQIP) is seeking to procure the following services for the National Joint Registry (NJR). \n•NJR data management, solutions, statistical analysis and reporting, and (optional) associated services\nHQIP is not only looking for organisations to provide these services but also to partner with organisations that can demonstrate the following characteristics:\n•Strategic and solution orientated\n•Proactive, responsive and flexible\n•Ability to add value\n•Committed to continual improvement\n•Communicative and effective team player\n•Innovative\nJoint replacements have become common and highly successful operations that bring many patients improved mobility and relief from pain. Thousands of such operations take place in the UK every year.\nA wide range of implants can be used in joint replacement operations and the NJR helps to monitor the performance of these implants and the effectiveness of different types of surgery; improving clinical standards and benefiting patients, clinicians and the orthopaedic industry.\nThe NJR was set up in April 2002 by the Department of Health (DH) and Welsh Government following a National Audit Office report into a failing ‘3M’ hip implant. From 1 April 2008, hosting arrangements for the NJR were transferred from the DH to HQIP. \nThe NJR has collected hip and knee replacement data since April 2003, ankle replacement data since April 2010 and data for elbow and shoulder replacements since April 2012. \nThe DH provided the initial start-up funding for the NJR. However, the system is now self-financing through a subscription charge on each ‘eligible’ hip, knee, ankle, elbow and shoulder implant which is payable by NHS Trusts (England), Health and Social Care Trusts (Northern Ireland), Local Health Boards (Wales) and independent (private) healthcare providers. The cost to the NHS was reduced in 2014 through a contributory financial subscription arrangement with the orthopaedic device industry whereby an annual subscription is charged for provision of the NJR Supplier Feedback service and other bespoke reporting. \nSince April 2014, the NJR subscription has been invoiced annually and the income managed in a dedicated fund at HQIP, governed by the NJR Board (NJRB). \nThe purpose of the National Joint Registry, which covers England, Wales, Northern Ireland, the Isle of Man, the States of Guernsey and the Channel Islands, is to collect high quality and relevant data about joint replacement surgery in order to provide an early warning of issues relating to patient safety. In a continuous drive to improve the quality of outcomes and ensure the quality and cost-effectiveness of joint replacement surgery, the NJR will monitor and report on outcomes, and support and enable related research.\nThe NJR’s strategic goals are to: \n•Monitor in real time the outcomes achieved by brand of prosthesis, hospital and surgeon, and highlight where these fall below an expected performance in order to allow prompt investigation and to support follow-up action.\n•Inform patients, clinicians, providers and commissioners of healthcare, regulators and implant suppliers of the outcomes achieved in joint replacement surgery.\n•Evidence variations in outcome achieved across surgical practice in order to inform best practice.\n•Enhance patient awareness of joint replacement outcomes to better inform patient choice and patients' quality of experience through engagement. \n•Support evidence-based purchasing of joint replacement implants for healthcare providers to support quality and cost effectiveness.\n•Support suppliers in the routine post-market surveillance of implants and provide information to clinicians, patients, hospital management and the regulatory authorities.\nCurrent Expectations - To be Defined\nCore service provision is expected to include:\n•Data systems and ingestion\n•Data processing and cleaning\n•Dynamic reporting and dashboards\n•Supplier feedback\n•Annual report statistical outputs\n•Outlier detection, reporting and analysis\n•PROMs  and PREMs collection\n•Service desk and operational support\nFurther details of the existing programme can be found at: https://www.njrcentre.org.uk/\nFor more information about this opportunity, please visit the eSourcing portal at: \nhttps://www.delta-esourcing.com/tenders/UK-UK-London:-Health-services./7449M9X8XA\nTo respond to this opportunity, please click here: \nhttps://www.delta-esourcing.com/respond/7449M9X8XA",
    "communication": {
      "futureNoticeDate": "2026-07-20T23:59:59+01:00"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-PPON-PVVQ-6113-CJWD",
      "name": "Healthcare Quality Improvement Partnership Ltd",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI43",
        "country": "GB",
        "locality": "London",
        "postalCode": "EC1V 2NX",
        "countryName": "United Kingdom",
        "streetAddress": "128 City Road"
      },
      "details": {
        "classifications": [
          {
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - sub-central government"
          }
        ]
      },
      "identifier": {
        "id": "PVVQ-6113-CJWD",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "email": "procurement@hqip.org.uk",
        "telephone": "0000000000"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "044829-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/044829-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-05-15T11:09:12+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-06-04T23:59:59+01:00",
        "description": "Healthcare Quality Improvement Partnership (HQIP) as hosts of the National Joint Registry are seeking to engage with the market on the recommissioning of the NJR Data Management, Solutions, Statistical Analysis, Reporting & Associated Services tender.\nThe Authority is looking to build on the successes of the existing programme currently contracted with NEC Software Solutions UK Limited. Further information as well as details of the current programme can be found at: \nhttps://www.necsws.com/case-studies/healthcare/national-joint-registry\nHQIP will be holding a pre-market engagement session with potential suppliers on Monday 8th June 2026 2.00pm-4.00pm.\nThis meeting will focus on the commissioning of a host for the NJR Data Management, Analysis & Associated Services. The session will then be followed by a closed meeting where funders will discuss the content of the premarket engagement session, and decide on the scope of the specification.\nAlso in attendance will be representatives from the patient network, incumbent supplier(s) and implant manufacturers. The aim of the pre-market engagement session is for interested parties to hear and contribute to discussions with system experts and patient groups that will feed into the NJR's final decisions on the scope of the tender during this next contract period, and the anticipated outcomes over the 5-7 years of the programme.\nThe existing specification is available for review by any interested parties and whilst it will provide information on how the current programme was scoped, it is important to understand that the recommissioning of this programme and its specification will be amended to suit future ambitions, including additions to requirements.\nAt this point, the Authority is planning to run this procurement under an open tender.\nThe proposed dates (subject to change solely at the Authority’s discretion) are as follows:\n•8th June 2026: Pre Market Engagement Session\n•Publication of tender opportunity: July - August 2026\n•Evaluation of submitted bids: October - November 2026\n•Award: January – February 2027\n•Mobilisation: February – August 2027\n•Contract start - 1st August 2027\nWhilst the Authority intends to stick to the timeline, it may deviate away from it at any time. The expected value of the contract will be subject to increase under aspirational intent measures which will be defined in the service specification at point of tender. \nThe authority cannot commit to the value and potential aspirational measures/additions at this stage, but it may become a requirement between the premarket engagement event and the tender opportunity going live.\nThe aspirational intent will cover the value range and mechanisms for invoking each element of it.\nIf you would like to join this premarket engagement event, please register by close of business on Thursday 4th June 2026 via: https://forms.office.com/e/MKKh28r8ty\nYou may also use this opportunity to request a copy of the existing project specification."
      }
    ]
  },
  "initiationType": "tender"
}